Small fiber neuropathy in the chronic phase of Chagas disease: a case report

2013 ◽  
Vol 23 (3) ◽  
pp. 149-153 ◽  
Author(s):  
Maria Nolano ◽  
V. Provitera ◽  
F. Manganelli ◽  
A. Pagano ◽  
A. Perretti ◽  
...  
2014 ◽  
Vol 111 (2) ◽  
pp. S22 ◽  
Author(s):  
Stephanie Austin ◽  
Lisa D. Hobson-Webb ◽  
Sneha Jain ◽  
Laura Case ◽  
Karla Greene ◽  
...  

PM&R ◽  
2014 ◽  
Vol 6 (9) ◽  
pp. S378
Author(s):  
Terin Euerle ◽  
Joline E. Brandenburg

2017 ◽  
Vol 2017 ◽  
pp. 1-3 ◽  
Author(s):  
Maxim Eckmann ◽  
Alexander Papanastassiou ◽  
Mark Awad

Spinal cord stimulators have commonly been used to treat multiple pain conditions. This case report represents a unique case of using multiple spinal cord stimulators for widespread small fiber neuropathy pain. This case report concerns patient JJ who first presented with generalized neuropathic pain. His pain was an intermittent burning, stinging quality that originally focused in both of his feet and progressed to include his legs and arms and eventually involved his entire body. The pain would last moments to hours at least daily. He reported a poor quality of life. He was diagnosed with small fiber neuropathy with anhydrosis, suggestive of idiopathic erythromelalgia. He had a spinal cord stimulator trial involving both cervical and lower thoracic percutaneous leads. After two spinal cord stimulators were implanted, the patient began to report an improvement in pain. The patient continues to report excellent pain relief. The patient uses the stimulator intermittently as needed, in an abortive fashion for pain flares. The patient is very pleased and has increased his activity. He now attends graduate school full time. This case report hopes to illustrate a unique use of multiple spinal cord stimulators in treating widespread neuropathic pain caused by small fiber neuropathy.


2017 ◽  
Vol 3 (20;3) ◽  
pp. E459-E463 ◽  
Author(s):  
Eva Koetsier

Small fiber neuropathy is a disorder of the peripheral nerves with typical symptoms of burning, sharp, and shooting pain and sensory disturbances in the feet. Pain treatment depends principally on the underlying etiology with concurrent administration of antidepressants, anticonvulsants, opioids, and topical treatments like capsaicin and local anesthetics. However, treatments for pain relief in these patients frequently fail. We describe the first case of intractable painful small fiber neuropathy of the foot successfully treated with spinal cord stimulation of the left L5 dorsal root ganglion. A 74-year-old man presented at our clinic with severe intractable pain, dysesthesia, and allodynia of the left foot caused by idiopathic small fiber neuropathy, confirmed by skin biopsy. His pain score was 8 on a standard 0 – 10 numeric rating scale. As the pain was not satisfactorily controlled by conventional therapy, dorsal root ganglion stimulation was proposed to the patient and, after informed consent, a specifically designed percutaneous stimulation lead was placed over the left L5 dorsal root ganglion and connected to an external neurostimulator. After a positive trial of 10 days, a permanent neurostimulator was implanted. Twenty months post-implantation the patient continued to experience stimulation-induced paresthesia covering the entire pain area and reported a pain rating of 4. Results from the case report demonstrate that the dorsal root ganglion is a promising neural stimulation target to treat neuropathic pain due to intractable small fiber neuropathy. Prospective controlled studies are warranted to confirm the efficacy of this treatment as an option for the aforementioned condition. Key words: Dorsal root ganglion stimulation, small fiber neuropathy, neuropathic pain


2006 ◽  
Vol 7 (3) ◽  
pp. 128-132 ◽  
Author(s):  
Michael D. Stubblefield ◽  
Christian M. Custodio ◽  
Petra Kaufmann ◽  
Maura N. Dickler

2006 ◽  
Vol 37 (5) ◽  
pp. 38
Author(s):  
JANE SALODOF MACNEIL

2004 ◽  
Vol 31 (S 1) ◽  
Author(s):  
Z Katsarava ◽  
Ö Yaldizli ◽  
C Voulkoudis ◽  
S Esser ◽  
HC Diener ◽  
...  

2019 ◽  
Vol 26 (36) ◽  
pp. 6519-6543 ◽  
Author(s):  
Adriana Egui ◽  
Paola Lasso ◽  
Elena Pérez-Antón ◽  
M. Carmen Thomas ◽  
Manuel Carlos López

Chagas disease courses with different clinical phases and has a variable clinical presentation and progression. The acute infection phase mostly exhibits a non-specific symptomatology. In the absence of treatment, the acute phase is followed by a chronic phase, which is initially asymptomatic. This chronic asymptomatic phase of the disease is characterized by a fragile balance between the host’s immune response and the parasite replication. The loss of this balance is crucial for the progression of the sickness. The virulence and tropism of the T. cruzi infecting strain together to the inflammation processes in the cardiac tissue are the main factors for the establishment and severity of the cardiomyopathy. The efficacy of treatment in chronic Chagas disease patients is controversial. However, several studies carried out in chronic patients demonstrated that antiparasitic treatment reduces parasite load in the bloodstream and leads to an improvement in the immune response against the Trypanosoma cruzi parasite. The present review is mainly focused on the cellular patterns associated to the clinical status and the evolution of the disease in chronic patients, as well as the effectiveness of the treatment related to T. cruzi infection control. Therefore, an emphasis is placed on the dynamics of specific-antigens T cell subpopulations, their memory and activation phenotypes, their functionality and their contribution to pathogenesis or disease control, as well as their association with risk of congenital transmission of the parasite.


Sign in / Sign up

Export Citation Format

Share Document